{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:06:09Z","timestamp":1784617569969,"version":"3.55.0"},"reference-count":41,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Behavioral Addictions"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1556\/jba.1.2012.2.6","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T02:14:14Z","timestamp":1352513654000},"page":"78-82","source":"Crossref","is-referenced-by-count":2,"title":["A case of severe adolescent obsessive-compulsive disorder treated with inpatient hospitalization, risperidone and sertraline"],"prefix":"10.1556","volume":"1","author":[{"given":"Mathew L.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"1","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2165\/00023210-200822080-00002","article-title":"Delirium and its treatment","volume":"22","author":"Attard A.","year":"2008","journal-title":"CNS Drugs"},{"key":"3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.psychres.2004.04.015","article-title":"Clinical picture of obsessive-compulsive disorder with poor insight: A regression model","volume":"136","author":"Bellino S.","year":"2005","journal-title":"Psychiatry Research"},{"key":"4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00004714-200204000-00007","article-title":"Sertraline and fluoxetine treatment of obsessive-compulsive disorder: Results of a double-blind, 6-month treatment study","volume":"22","author":"Bergeron R.","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"5","first-page":"50","article-title":"The diagnosis and treatment of adolescent anxiety disorders","volume":"51","author":"Biederman J.","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"key":"6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.pra.0000320112.36648.3e","article-title":"Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting","volume":"14","author":"Bj\u00f6rgvinsson T.","year":"2008","journal-title":"Journal of Psychiatric Practice"},{"key":"7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch M. H.","year":"2006","journal-title":"Molecular Psychiatry"},{"key":"8","first-page":"265","article-title":"Clonazepam in the treatment of obsessive-compulsive disorder associated with panic disorder in one patient","volume":"50","author":"Bodkin J. A.","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"key":"9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10401230490486972","article-title":"A double-blind combination study of clonazepam with sertraline for obsessive-compulsive disorder","volume":"16","author":"Crockett B. A.","year":"2004","journal-title":"Annals of Clinical Psychiatry"},{"key":"10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/NDT.S3149","article-title":"Current trends in drug treatment of obsessive-compulsive disorder","volume":"6","author":"Decloedt E. H.","year":"2010","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"11","first-page":"11","article-title":"The role of dopamine in obsessive-compulsive disorder: Preclinical and clinical evidence","volume":"65","author":"Denys D.","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/jclp.20083","article-title":"Pharmacotherapy for obsessive-compulsive disorder","volume":"60","author":"Dougherty D. D.","year":"2004","journal-title":"J. Clin. Psychol."},{"key":"13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: A review","volume":"67","author":"Gao K.","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"14","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1002\/da.20448","article-title":"Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder","volume":"26","author":"Goldstein R. B.","year":"2009","journal-title":"Depression and Anxiety"},{"key":"15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1207\/S15374424JCCP3001_8","article-title":"Pharmacological treatment of childhood obsessive-compulsive disorder: From theory to practice","volume":"30","author":"Grados M. A.","year":"2001","journal-title":"Journal of Clinical Child Psychology"},{"key":"16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/15622970309167908","article-title":"A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder","volume":"4","author":"Hollander E.","year":"2003","journal-title":"World Journal of Biological Psychiatry"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ipser, J. C., Stein, D. J., Hawkridge, S. & Hoppe, L. (2009). Pharmacotherapy for anxiety disorders in children and adolescents. <i>Cochrane Database of Systematic Reviews, July 8 2009(3)<\/i>, CD005170.","DOI":"10.1002\/14651858.CD005170.pub2"},{"key":"18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0005-7967(94)90132-5","article-title":"Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder","volume":"32","author":"Kozak M. J.","year":"1994","journal-title":"Behaviour Research and Therapy"},{"key":"19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1592\/phco.30.9.942","article-title":"Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder","volume":"30","author":"Lorenz R. A.","year":"2010","journal-title":"Pharmacotherapy"},{"key":"20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00023210-200923030-00005","article-title":"Pharmacotherapy in paediatric obsessive-compulsive disorder: A naturalistic, retrospective study","volume":"23","author":"Masi G.","year":"2009","journal-title":"CNS Drugs"},{"key":"21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle C. J.","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"22","first-page":"170","article-title":"Effective short-term treatment of generalized anxiety disorder with trifluoperazine","volume":"47","author":"Mendels J.","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/3-540-28082-0_17","article-title":"Pharmacotherapy of anxiety","volume":"169","author":"Nash J. R.","year":"2005","journal-title":"Handbook of Experimental Pharmacology"},{"key":"24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2008.11.023","article-title":"Obsessive compulsive symptoms in the psychosis prodrome: Correlates of clinical and functional outcome","volume":"108","author":"Niendam T. A.","year":"2009","journal-title":"Schizophrenia Research"},{"key":"25","first-page":"34","article-title":"Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: Issues in the treatment of a patient in need","volume":"66","author":"Otto M. W.","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pneurobio.2009.10.010","article-title":"Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis","volume":"90","author":"Perez de la Mora M.","year":"2010","journal-title":"Progress in Neurobiology"},{"key":"27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2004.09.004","article-title":"Mesolimbic dopaminergic pathways in fear conditioning","volume":"74","author":"Pezze M. A.","year":"2004","journal-title":"Progress in Neurobiology"},{"key":"28","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder","volume":"292","year":"2004","journal-title":"Journal of the American Medical Association"},{"key":"29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881108096508","article-title":"Intravenous anti-obsessive agents: A review","volume":"24","author":"Ravindran L. N.","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.chc.2005.06.004","article-title":"Psychopharmacologic treatment of pediatric anxiety disorders","volume":"14","author":"Reinblatt S. P.","year":"2005","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/cap.2007.0027","article-title":"Childhood obsessive-compulsive disorder presenting as schizophrenia spectrum disorders","volume":"18","author":"Rodowski M. F.","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1744-6171.1993.tb00165.x","article-title":"Inpatient treatment of obsessive-compulsive disorder in childhood: A case study","volume":"6","author":"Scahill L.","year":"1993","journal-title":"J. Child. Adolesc. Psychiatr. Ment. Health Nurs."},{"key":"33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/da.20135","article-title":"Clinical characteristics of inpatient adolescents with severe obsessive-compulsive disorder","volume":"23","author":"Shoval G.","year":"2006","journal-title":"Depression and Anxiety"},{"key":"34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/070674378703200712","article-title":"Alprazolam effects in children with anxiety disorders","volume":"32","author":"Simeon J. G.","year":"1987","journal-title":"Canadian Journal of Psychiatry"},{"key":"35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/ajp.141.5.689","article-title":"Alprazolam as treatment for a case of obsessive-compulsive disorder","volume":"141","author":"Tesar G. E.","year":"1984","journal-title":"American Journal of Psychiatry"},{"key":"36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007870050038","article-title":"Obsessive-compulsive disorder in children and adolescents: Clinical guidelines","volume":"7","author":"Thomsen P. H.","year":"1998","journal-title":"European Child and Adolescent Psychiatry"},{"key":"37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10401230490522016","article-title":"Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: A case series","volume":"16","author":"Thomsen P. H.","year":"2004","journal-title":"Annals of Clinical Psychiatry"},{"key":"38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.psychres.2007.07.031","article-title":"Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: A neuropsychological comparison","volume":"165","author":"Tumkaya S.","year":"2009","journal-title":"Psychiatry Research"},{"key":"39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/S1092852900002479","article-title":"Neurobiology of obsessive-compulsive disorder: Serotonin and beyond","volume":"12","author":"Westenberg H. G. M.","year":"2007","journal-title":"CNS Spectrums"},{"key":"40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0887-6185(02)00091-9","article-title":"Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia","volume":"16","author":"Westra H. A.","year":"2002","journal-title":"Journal of Anxiety Disorders"},{"key":"41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11126-005-2982-5","article-title":"Review of benzodiazepine use in children and adolescents","volume":"76","author":"Witek M. W.","year":"2005","journal-title":"Psychiatric Quarterly"}],"container-title":["Journal of Behavioral Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/jba.1.2012.2.6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:50:10Z","timestamp":1590141010000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/jba.1.2012.2.6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1556\/JBA.1.2012.2.6"],"URL":"https:\/\/doi.org\/10.1556\/jba.1.2012.2.6","relation":{},"ISSN":["2062-5871","2063-5303"],"issn-type":[{"value":"2062-5871","type":"print"},{"value":"2063-5303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}